U.S. flag

An official website of the United States government

NM_000540.3(RYR1):c.11731A>G (p.Thr3911Ala) AND Malignant hyperthermia, susceptibility to, 1

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Jan 11, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000209970.4

Allele description [Variation Report for NM_000540.3(RYR1):c.11731A>G (p.Thr3911Ala)]

NM_000540.3(RYR1):c.11731A>G (p.Thr3911Ala)

Gene:
RYR1:ryanodine receptor 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19q13.2
Genomic location:
Preferred name:
NM_000540.3(RYR1):c.11731A>G (p.Thr3911Ala)
HGVS:
  • NC_000019.10:g.38543388A>G
  • NG_008866.1:g.114689A>G
  • NM_000540.3:c.11731A>GMANE SELECT
  • NM_001042723.2:c.11716A>G
  • NP_000531.2:p.Thr3911Ala
  • NP_000531.2:p.Thr3911Ala
  • NP_001036188.1:p.Thr3906Ala
  • LRG_766t1:c.11731A>G
  • LRG_766:g.114689A>G
  • LRG_766p1:p.Thr3911Ala
  • NC_000019.9:g.39034028A>G
  • NM_000540.2:c.11731A>G
Protein change:
T3906A
Links:
dbSNP: rs200622493
NCBI 1000 Genomes Browser:
rs200622493
Molecular consequence:
  • NM_000540.3:c.11731A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001042723.2:c.11716A>G - missense variant - [Sequence Ontology: SO:0001583]
Observations:
15

Condition(s)

Name:
Malignant hyperthermia, susceptibility to, 1 (MHS1)
Synonyms:
Anesthesia related hyperthermia; Malignant hyperpyrexia; Fulminating hyperpyrexia; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0007783; MedGen: C2930980; Orphanet: 423; OMIM: 145600

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000265743Biesecker Lab/Clinical Genomics Section, National Institutes of Health - ClinSeq
criteria provided, single submitter

(Gonsalves et al. 2013)
Uncertain significance
(Jul 1, 2013)
unknownresearch

PubMed (1)
[See all records that cite this PMID]

SCV004821744All of Us Research Program, National Institutes of Health
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain Significance
(Jan 11, 2024)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown15not providednot provided108544not providedclinical testing
not providedunknownunknown1not providednot providednot providednot providedresearch

Citations

PubMed

Using exome data to identify malignant hyperthermia susceptibility mutations.

Gonsalves SG, Ng D, Johnston JJ, Teer JK, Stenson PD, Cooper DN, Mullikin JC, Biesecker LG; NISC Comparative Sequencing Program..

Anesthesiology. 2013 Nov;119(5):1043-53. doi: 10.1097/ALN.0b013e3182a8a8e7.

PubMed [citation]
PMID:
24195946
PMCID:
PMC4077354

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Biesecker Lab/Clinical Genomics Section, National Institutes of Health - ClinSeq, SCV000265743.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedresearch PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot provided1not providednot providednot provided

From All of Us Research Program, National Institutes of Health, SCV004821744.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided15not providednot providedclinical testing PubMed (1)

Description

This missense variant replaces threonine with alanine at codon 3911 of the RYR1 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with RYR1-related disorders in the literature. This variant has been identified in 27/251492 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknown108544not providednot provided15not providednot providednot provided

Last Updated: Sep 8, 2024